Cargando…
Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial
BACKGROUND: Stigma associated with mental disorders is rooted among many pharmacists, and represents a major barrier to patient support in community-based psychiatry. We developed an assessment scale that is specifically designed to assess the level of stigma that pharmacists may have toward schizop...
Autores principales: | Fujii, Tomoo, Hanya, Manako, Murotani, Kenta, Kamei, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077925/ https://www.ncbi.nlm.nih.gov/pubmed/33902519 http://dx.doi.org/10.1186/s12888-021-03208-z |
Ejemplares similares
-
Usefulness of a psychomotor function test as a cognitive function scale for patients with schizophrenia: A pilot study
por: Kamei, Hiroyuki, et al.
Publicado: (2021) -
Effects of communication skill training (CST) based on SPIKES for insurance-covered pharmacy pharmacists to interact with simulated cancer patients
por: Hanya, Manako, et al.
Publicado: (2017) -
Effect of Adenine on Clozapine-induced Neutropenia in Patients with Schizophrenia: A Preliminary Study
por: Takeuchi, Ippei, et al.
Publicado: (2015) -
Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series
por: Kamei, Hiroyuki, et al.
Publicado: (2020) -
Subjective assessment of brexpiprazole in patients with schizophrenia: a prospective observational study
por: Yokoi, Rina, et al.
Publicado: (2023)